The global Nucleic Acid-based Therapeutics market is projected to grow from US$ 560.8 million in 2023 to US$ 705.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.

Nucleic Acid-based Therapeutics Market

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

Market Analysis and Insights: Global Nucleic Acid-based Therapeutics Market

Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.

Report Includes

This report presents an overview of global market for Nucleic Acid-based Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Nucleic Acid-based Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid-based Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nucleic Acid-based Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Nucleic Acid-based Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Nucleic Acid-based Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica and Transgene, etc.

Scope of Nucleic Acid-based Therapeutics Market Report

Report Metric	Details
Report Name	Nucleic Acid-based Therapeutics Market
Accounted market size in 2023	US$ 560.8 million
Forecasted market size in 2029	US$ 705.5 million
CAGR	3.9
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Anti-Sense And Anti-Gene Short Inhibitory Sequences Gene Transfer Therapy Nucleoside Analogs Ribozymes Aptamers
Segment by Application	Hospitals Academic & Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, Copernicus Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nucleic Acid-based Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid-based Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid-based Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Nucleic Acid-based Therapeutics Market growing?

Ans: The Nucleic Acid-based Therapeutics Market witnessing a CAGR of 3.9 during the forecast period 2023-2029.

What is the Nucleic Acid-based Therapeutics Market size in 2029?

Ans: The global Nucleic Acid-based Therapeutics market is projected to grow from US$ 560.8 million in 2023 to US$ 705.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.

Who are the main players in the Nucleic Acid-based Therapeutics Market report?

Ans: The main players in the Nucleic Acid-based Therapeutics Market are Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, Copernicus Therapeutics

What are the Application segmentation covered in the Nucleic Acid-based Therapeutics Market report?

Ans: The Applications covered in the Nucleic Acid-based Therapeutics Market report are Hospitals, Academic & Research Institutes

What are the Type segmentation covered in the Nucleic Acid-based Therapeutics Market report?

Ans: The Types covered in the Nucleic Acid-based Therapeutics Market report are Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Anti-Sense And Anti-Gene

1.2.3 Short Inhibitory Sequences

1.2.4 Gene Transfer Therapy

1.2.5 Nucleoside Analogs

1.2.6 Ribozymes

1.2.7 Aptamers

1.3 Market by Application

1.3.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Academic & Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nucleic Acid-based Therapeutics Market Perspective (2018-2029)

2.2 Global Nucleic Acid-based Therapeutics Growth Trends by Region

2.2.1 Nucleic Acid-based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Nucleic Acid-based Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Nucleic Acid-based Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Nucleic Acid-based Therapeutics Market Dynamics

2.3.1 Nucleic Acid-based Therapeutics Industry Trends

2.3.2 Nucleic Acid-based Therapeutics Market Drivers

2.3.3 Nucleic Acid-based Therapeutics Market Challenges

2.3.4 Nucleic Acid-based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Nucleic Acid-based Therapeutics by Players

3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Players (2018-2023)

3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Nucleic Acid-based Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Nucleic Acid-based Therapeutics Market Concentration Ratio

3.4.1 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Therapeutics Revenue in 2022

3.5 Global Key Players of Nucleic Acid-based Therapeutics Head office and Area Served

3.6 Global Key Players of Nucleic Acid-based Therapeutics, Product and Application

3.7 Global Key Players of Nucleic Acid-based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-based Therapeutics Breakdown Data by Type

4.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2024-2029)

5 Nucleic Acid-based Therapeutics Breakdown Data by Application

5.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Nucleic Acid-based Therapeutics Market Size (2018-2029)

6.2 North America Nucleic Acid-based Therapeutics Market Size by Type

6.2.1 North America Nucleic Acid-based Therapeutics Market Size by Type (2018-2023)

6.2.2 North America Nucleic Acid-based Therapeutics Market Size by Type (2024-2029)

6.2.3 North America Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

6.3 North America Nucleic Acid-based Therapeutics Market Size by Application

6.3.1 North America Nucleic Acid-based Therapeutics Market Size by Application (2018-2023)

6.3.2 North America Nucleic Acid-based Therapeutics Market Size by Application (2024-2029)

6.3.3 North America Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

6.4 North America Nucleic Acid-based Therapeutics Market Size by Country

6.4.1 North America Nucleic Acid-based Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Nucleic Acid-based Therapeutics Market Size by Country (2018-2023)

6.4.3 North America Nucleic Acid-based Therapeutics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Nucleic Acid-based Therapeutics Market Size (2018-2029)

7.2 Europe Nucleic Acid-based Therapeutics Market Size by Type

7.2.1 Europe Nucleic Acid-based Therapeutics Market Size by Type (2018-2023)

7.2.2 Europe Nucleic Acid-based Therapeutics Market Size by Type (2024-2029)

7.2.3 Europe Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

7.3 Europe Nucleic Acid-based Therapeutics Market Size by Application

7.3.1 Europe Nucleic Acid-based Therapeutics Market Size by Application (2018-2023)

7.3.2 Europe Nucleic Acid-based Therapeutics Market Size by Application (2024-2029)

7.3.3 Europe Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

7.4 Europe Nucleic Acid-based Therapeutics Market Size by Country

7.4.1 Europe Nucleic Acid-based Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Nucleic Acid-based Therapeutics Market Size by Country (2018-2023)

7.4.3 Europe Nucleic Acid-based Therapeutics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Nucleic Acid-based Therapeutics Market Size (2018-2029)

8.2 China Nucleic Acid-based Therapeutics Market Size by Type

8.2.1 China Nucleic Acid-based Therapeutics Market Size by Type (2018-2023)

8.2.2 China Nucleic Acid-based Therapeutics Market Size by Type (2024-2029)

8.2.3 China Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

8.3 China Nucleic Acid-based Therapeutics Market Size by Application

8.3.1 China Nucleic Acid-based Therapeutics Market Size by Application (2018-2023)

8.3.2 China Nucleic Acid-based Therapeutics Market Size by Application (2024-2029)

8.3.3 China Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Nucleic Acid-based Therapeutics Market Size (2018-2029)

9.2 Asia Nucleic Acid-based Therapeutics Market Size by Type

9.2.1 Asia Nucleic Acid-based Therapeutics Market Size by Type (2018-2023)

9.2.2 Asia Nucleic Acid-based Therapeutics Market Size by Type (2024-2029)

9.2.3 Asia Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

9.3 Asia Nucleic Acid-based Therapeutics Market Size by Application

9.3.1 Asia Nucleic Acid-based Therapeutics Market Size by Application (2018-2023)

9.3.2 Asia Nucleic Acid-based Therapeutics Market Size by Application (2024-2029)

9.3.3 Asia Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

9.4 Asia Nucleic Acid-based Therapeutics Market Size by Region

9.4.1 Asia Nucleic Acid-based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Nucleic Acid-based Therapeutics Market Size by Region (2018-2023)

9.4.3 Asia Nucleic Acid-based Therapeutics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Wave Life Sciences

11.1.1 Wave Life Sciences Company Details

11.1.2 Wave Life Sciences Business Overview

11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Introduction

11.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.1.5 Wave Life Sciences Recent Developments

11.2 Imugene

11.2.1 Imugene Company Details

11.2.2 Imugene Business Overview

11.2.3 Imugene Nucleic Acid-based Therapeutics Introduction

11.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.2.5 Imugene Recent Developments

11.3 Caperna

11.3.1 Caperna Company Details

11.3.2 Caperna Business Overview

11.3.3 Caperna Nucleic Acid-based Therapeutics Introduction

11.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.3.5 Caperna Recent Developments

11.4 Phylogica

11.4.1 Phylogica Company Details

11.4.2 Phylogica Business Overview

11.4.3 Phylogica Nucleic Acid-based Therapeutics Introduction

11.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.4.5 Phylogica Recent Developments

11.5 Protagonist Therapeutics

11.5.1 Protagonist Therapeutics Company Details

11.5.2 Protagonist Therapeutics Business Overview

11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Introduction

11.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.5.5 Protagonist Therapeutics Recent Developments

11.6 Benitec Biopharma

11.6.1 Benitec Biopharma Company Details

11.6.2 Benitec Biopharma Business Overview

11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Introduction

11.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.6.5 Benitec Biopharma Recent Developments

11.7 EGEN

11.7.1 EGEN Company Details

11.7.2 EGEN Business Overview

11.7.3 EGEN Nucleic Acid-based Therapeutics Introduction

11.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.7.5 EGEN Recent Developments

11.8 BioMedica

11.8.1 BioMedica Company Details

11.8.2 BioMedica Business Overview

11.8.3 BioMedica Nucleic Acid-based Therapeutics Introduction

11.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.8.5 BioMedica Recent Developments

11.9 Transgene

11.9.1 Transgene Company Details

11.9.2 Transgene Business Overview

11.9.3 Transgene Nucleic Acid-based Therapeutics Introduction

11.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.9.5 Transgene Recent Developments

11.10 Copernicus Therapeutics

11.10.1 Copernicus Therapeutics Company Details

11.10.2 Copernicus Therapeutics Business Overview

11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Introduction

11.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2018-2023)

11.10.5 Copernicus Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Protagonist Therapeutics

Copernicus Therapeutics

List of Tables

Table 1. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Anti-Sense And Anti-Gene

Table 3. Key Players of Short Inhibitory Sequences

Table 4. Key Players of Gene Transfer Therapy

Table 5. Key Players of Nucleoside Analogs

Table 6. Key Players of Ribozymes

Table 7. Key Players of Aptamers

Table 8. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 9. Global Nucleic Acid-based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 10. Global Nucleic Acid-based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 11. Global Nucleic Acid-based Therapeutics Market Share by Region (2018-2023)

Table 12. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 13. Global Nucleic Acid-based Therapeutics Market Share by Region (2024-2029)

Table 14. Nucleic Acid-based Therapeutics Market Trends

Table 15. Nucleic Acid-based Therapeutics Market Drivers

Table 16. Nucleic Acid-based Therapeutics Market Challenges

Table 17. Nucleic Acid-based Therapeutics Market Restraints

Table 18. Global Nucleic Acid-based Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 19. Global Nucleic Acid-based Therapeutics Revenue Share by Players (2018-2023)

Table 20. Global Top Nucleic Acid-based Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2022)

Table 21. Global Nucleic Acid-based Therapeutics Industry Ranking 2021 VS 2022 VS 2023

Table 22. Global 5 Largest Players Market Share by Nucleic Acid-based Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 23. Global Key Players of Nucleic Acid-based Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Nucleic Acid-based Therapeutics, Product and Application

Table 25. Global Key Players of Nucleic Acid-based Therapeutics, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 28. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2018-2023)

Table 29. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 30. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2024-2029)

Table 31. Global Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 32. Global Nucleic Acid-based Therapeutics Revenue Share by Application (2018-2023)

Table 33. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 34. Global Nucleic Acid-based Therapeutics Revenue Share by Application (2024-2029)

Table 35. North America Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 36. North America Nucleic Acid-based Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 37. North America Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 38. North America Nucleic Acid-based Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 39. North America Nucleic Acid-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 40. North America Nucleic Acid-based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 41. North America Nucleic Acid-based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 42. Europe Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 43. Europe Nucleic Acid-based Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 44. Europe Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 45. Europe Nucleic Acid-based Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 46. Europe Nucleic Acid-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 47. Europe Nucleic Acid-based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 48. Europe Nucleic Acid-based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 49. China Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 50. China Nucleic Acid-based Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 51. China Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 52. China Nucleic Acid-based Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 54. Asia Nucleic Acid-based Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 55. Asia Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 56. Asia Nucleic Acid-based Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 57. Asia Nucleic Acid-based Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 58. Asia Nucleic Acid-based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 59. Asia Nucleic Acid-based Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 65. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 67. Wave Life Sciences Company Details

Table 68. Wave Life Sciences Business Overview

Table 69. Wave Life Sciences Nucleic Acid-based Therapeutics Product

Table 70. Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 71. Wave Life Sciences Recent Developments

Table 72. Imugene Company Details

Table 73. Imugene Business Overview

Table 74. Imugene Nucleic Acid-based Therapeutics Product

Table 75. Imugene Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 76. Imugene Recent Developments

Table 77. Caperna Company Details

Table 78. Caperna Business Overview

Table 79. Caperna Nucleic Acid-based Therapeutics Product

Table 80. Caperna Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 81. Caperna Recent Developments

Table 82. Phylogica Company Details

Table 83. Phylogica Business Overview

Table 84. Phylogica Nucleic Acid-based Therapeutics Product

Table 85. Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 86. Phylogica Recent Developments

Table 87. Protagonist Therapeutics Company Details

Table 88. Protagonist Therapeutics Business Overview

Table 89. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product

Table 90. Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 91. Protagonist Therapeutics Recent Developments

Table 92. Benitec Biopharma Company Details

Table 93. Benitec Biopharma Business Overview

Table 94. Benitec Biopharma Nucleic Acid-based Therapeutics Product

Table 95. Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 96. Benitec Biopharma Recent Developments

Table 97. EGEN Company Details

Table 98. EGEN Business Overview

Table 99. EGEN Nucleic Acid-based Therapeutics Product

Table 100. EGEN Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 101. EGEN Recent Developments

Table 102. BioMedica Company Details

Table 103. BioMedica Business Overview

Table 104. BioMedica Nucleic Acid-based Therapeutics Product

Table 105. BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 106. BioMedica Recent Developments

Table 107. Transgene Company Details

Table 108. Transgene Business Overview

Table 109. Transgene Nucleic Acid-based Therapeutics Product

Table 110. Transgene Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 111. Transgene Recent Developments

Table 112. Copernicus Therapeutics Company Details

Table 113. Copernicus Therapeutics Business Overview

Table 114. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product

Table 115. Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2018-2023) & (US$ Million)

Table 116. Copernicus Therapeutics Recent Developments

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Nucleic Acid-based Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. Anti-Sense And Anti-Gene Features

Figure 4. Short Inhibitory Sequences Features

Figure 5. Gene Transfer Therapy Features

Figure 6. Nucleoside Analogs Features

Figure 7. Ribozymes Features

Figure 8. Aptamers Features

Figure 9. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 10. Global Nucleic Acid-based Therapeutics Market Share by Application: 2022 VS 2029

Figure 11. Hospitals Case Studies

Figure 12. Academic & Research Institutes Case Studies

Figure 13. Nucleic Acid-based Therapeutics Report Years Considered

Figure 14. Global Nucleic Acid-based Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 15. Global Nucleic Acid-based Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Nucleic Acid-based Therapeutics Market Share by Region: 2022 VS 2029

Figure 17. Global Nucleic Acid-based Therapeutics Market Share by Players in 2022

Figure 18. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2022)

Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid-based Therapeutics Revenue in 2022

Figure 20. North America Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. North America Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

Figure 22. North America Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

Figure 23. North America Nucleic Acid-based Therapeutics Market Share by Country (2018-2029)

Figure 24. United States Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Canada Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Europe Nucleic Acid-based Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 27. Europe Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

Figure 28. Europe Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

Figure 29. Europe Nucleic Acid-based Therapeutics Market Share by Country (2018-2029)

Figure 30. Germany Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. France Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. U.K. Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Italy Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Russia Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Nordic Countries Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. China Nucleic Acid-based Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 37. China Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

Figure 38. China Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

Figure 39. Asia Nucleic Acid-based Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 40. Asia Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

Figure 41. Asia Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

Figure 42. Asia Nucleic Acid-based Therapeutics Market Share by Region (2018-2029)

Figure 43. Japan Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. South Korea Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. China Taiwan Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Southeast Asia Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. India Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Australia Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Share by Type (2018-2029)

Figure 51. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Share by Application (2018-2029)

Figure 52. Middle East, Africa, and Latin America Nucleic Acid-based Therapeutics Market Share by Country (2018-2029)

Figure 53. Brazil Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Mexico Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Turkey Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Saudi Arabia Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Israel Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. GCC Countries Nucleic Acid-based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 60. Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 61. Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 62. Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 63. Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 64. Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 65. EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 66. BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 67. Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 68. Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2018-2023)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions